Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome
about
Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells.Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoringER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer.Tissue microarrays and quantitative tissue-based image analysis as a tool for oncology biomarker and diagnostic development.Validation of the CPS + EG Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma.A novel, automated technology for multiplex biomarker imaging and application to breast cancer.A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2.
P2860
Q27302276-F9B67A6B-D799-442F-AA94-3E9D24642014Q35170197-340A35F7-A7F8-45A4-BF9F-BCC47A58AF85Q35609695-80BFB633-0C72-450C-BB18-DEB050A08AFAQ36048767-CDB4D95A-B205-47B0-B6AF-2DD7B6EF3B8FQ36245537-299F0673-0D85-4E0E-8C1D-4C3186F8DA9BQ38088419-DDDC99A6-5BAC-4D7A-9FD9-73043E58C82CQ39666322-73700C82-4512-4571-A75C-025CE765975EQ40217601-5AA2BFBE-2664-4D10-B096-AC3F39293ADFQ46972568-F9D11E85-52D1-4743-B68E-3E0BF696B971Q51371303-3577B277-2E0F-4E00-B1C1-8B49A84ADD23
P2860
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multiplexed assessment of the ...... e associated with poor outcome
@ast
Multiplexed assessment of the ...... e associated with poor outcome
@en
type
label
Multiplexed assessment of the ...... e associated with poor outcome
@ast
Multiplexed assessment of the ...... e associated with poor outcome
@en
prefLabel
Multiplexed assessment of the ...... e associated with poor outcome
@ast
Multiplexed assessment of the ...... e associated with poor outcome
@en
P2093
P2860
P1476
Multiplexed assessment of the ...... e associated with poor outcome
@en
P2093
Charles Haskell
Charles Shapiro
Daniel F Hayes
David L Rimm
Gabriel N Hortobagyi
George Sledge
Greg Tedeschi
I-Tien Yeh
James N Ingle
Malini Harigopal
P2860
P304
P356
10.2353/AJPATH.2010.090711
P407
P577
2010-02-11T00:00:00Z